ARCHIVES

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

NCI AIDS Malignancy Bank Accepts Requests; RFA Available

December 1, 1995

Also NCI appoints members of Clinical Trials Working Group to review trials system.

January 9, 2004

The Lancet Oncology Issues “Expression Of Concern” Over Paper

July 23, 2010

Breast Density Does Not Raise Breast Cancer Death Rates

August 31, 2012

Vaccine Prevented Cervical Pre-Cancers, Non-Invasive Cancers In Phase III Trial

October 28, 2005